<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23560129</article-id>
      <article-id pub-id-type="pmc">3612905</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-14-46</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2013.14.46.2235</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Images in Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Erosive nappy erythema following sunitinib intake</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kharmoum</surname>
            <given-names>Saoussane</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Errihani</surname>
            <given-names>Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Department of medical oncology, National institute of oncology, Rabat Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Saoussane Kharmoum MD, Department of medical oncology, National institute of oncology, Rabat Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>46</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Saoussane Kharmoum et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Erosive</kwd>
        <kwd>erythema</kwd>
        <kwd>sunitinib</kwd>
        <kwd>antiangiogenic drug</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S0001">
      <title>Image in medicine</title>
      <p>We report on the case of a 54 years old man treating for a metastatic renal carcinoma who had experienced a dermatological toxicity referring to sunitinb intake. The antiangiogenic drug was delivered at a daily dose of 50mg for 4 weeks followed by two weeks of rest. By the second week of treatment the patient presented a nappy erythema evolving towards erosive lesions bleeding at mild friction and extending to the perianal and scrotal area, the process fulfilled the maximal intensity at 4 weeks and improved after the discontinuation of sunitinib. The patient refused the reintroduction of the drug. No skin biopsy was developed seeing that the lesions disappeared 4 weeks later. <xref ref-type="fig" rid="F0001">Figure 1</xref>
</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Erosive nappy erythema (A) and scrotal erythema (B)</p>
        </caption>
        <graphic xlink:href="PAMJ-14-46-g001"/>
      </fig>
    </sec>
  </body>
</article>
</pmc-articleset>
